Graves Ofthalmopathy clinical trials

Explore recruiting graves ofthalmopathy clinical trials.

Also recruiting in Europe

Graves Ofthalmopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) with Atorvastatin (ATORGO)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Graves Ofthalmopathy trials by city

Graves Ofthalmopathy in Toronto Graves Ofthalmopathy in Vancouver Graves Ofthalmopathy in Montreal Graves Ofthalmopathy in Calgary Graves Ofthalmopathy in Edmonton Graves Ofthalmopathy in Ottawa Graves Ofthalmopathy in Winnipeg Graves Ofthalmopathy in Quebec City Graves Ofthalmopathy in Hamilton Graves Ofthalmopathy in Kitchener Graves Ofthalmopathy in London Graves Ofthalmopathy in Halifax Graves Ofthalmopathy in New York Graves Ofthalmopathy in Los Angeles Graves Ofthalmopathy in Chicago Graves Ofthalmopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease